Vantage Point: PMRG

Share this article:

Despite a 2009 that both sides of the healthcare marketing research table would readily admit was less than uplifting, PMRG attracted several hundred people to its fall event in Philadelphia. Especially encouraging was the client turnout, indicating that pharma marketing researchers continue to find value in attending.

A number of other good things happened at PMRG. Let me highlight two. First, I would like to congratulate my colleague, Susan Schwartz McDonald, PhD, president and CEO, National Analysts Worldwide, for receiving the RR Fordyce Award for her contributions to our profession. She has been, and remains, an intellectual leader in our field, a staunch advocate of our specialty in the broader field of marketing research, someone who is not afraid to appear in court to apply her expertise assisting litigants who she believes are right, and a successful businesswoman to boot. Our industry could use a lot more people like her, and that is what the Fordyce award is supposed to signify.

The second thing that grabbed me was Jonathan Salem Baskin's keynote presentation. Based on his book, Branding Only Works on Cattle, Jonathan made the point that while branding can get someone to remember a product's personality, it doesn't sell anything. Sales require “behavior.” In the eye of this beholder, Jonathan's presentation supported a theme that the healthcare marketing model needs a major overhaul and must separate itself from the practices of other marketing sectors on which we have relied for decades. Cute taglines, creative graphics and similar ploys will increasingly fall by the wayside, and the “behavior” to which Baskin alludes, e.g., superior performance at optimal pricing, will carry the day.  

Richard Vanderveer is CEO of GfK Healthcare

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Vantage Point

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Vantage Point

Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Vantage Point: Determining "fair market value"

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?

Vantage Point: Marketing Support for Clinical Trials

Vantage Point: Marketing Support for Clinical Trials

Pharmaceutical companies must provide robust marketing support for their clinical trials